EUVIMEDEUVIMED entdecken
Crossref

Electrogenic HfO2/TiO2 Living Biointerface Dismantles Metabolic Radioresistance for Amplified Radio-Immunotherapy

Mengen Guo, Pengcheng Sun, Wenjie Xu, Xinyan Hao, Tiantian Tang, Xinying Liu, Dehua Liao, Jiangshan Zhao, Hai Huang, Muyan Li, Linghao Xu, Jianing Lin und 5 weitere

ACS Nano · 2026

DOI: 10.1021/acsnano.6c08241 ↗

Kurz gefasst

Fachartikel in der Zeitschrift ACS Nano, 2026. Verfasst von Mengen Guo und 16 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy, The Second Xiangya Hospital of Central South University, Changsha, Hunan410011, China. Hauptthemen laut MEDLINE: Titanium, Radiation Tolerance, Shewanella, Oxides. Die Arbeit nennt 36 Literaturangaben. Gefördert von: Central South University, Xiangya Hospital, Central South University, Science and Technology Program of Hunan Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Radiotherapy (RT) efficacy in aggressive solid tumors is hindered by lactate-driven metabolic radioresistance and an immunosuppressive microenvironment. Here, we engineer a living biointerface (SHT) via in situ biomineralization of HfO2/TiO2 onto an electrogenic Shewanella oneidensis chassis to address this multifaceted challenge. This structural integration bridges the bacterial metabolism with interfacial radiocatalysis. The TiO2 shell acts as an efficient electron acceptor to accelerate bacterial extracellular electron transfer, driving rapid intratumoral lactate depletion, while the high-Z HfO2 core enhances the X-ray energy deposition. Under irradiation, this synergistic biointerface initiates an oxidative burst and irreversible DNA damage, dismantling the lactate-associated antioxidant defense. In radioresistant triple-negative breast cancer models, this localized physicochemical disruption translates into tumor suppression, accompanied by immunogenic cell death and cGAS-STING pathway activation, reprogramming the immunosuppressive niche. Furthermore, the SHT platform demonstrates systemic biocompatibility, alongside RT-gated self-limiting clearance. Collectively, this work establishes a bioelectrogenic material platform that integrates metabolic barrier dismantling, radiocatalytic sensitization, and immune remodeling for refractory cancer therapy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

TitaniumRadiation ToleranceShewanellaOxidesImmunotherapyTriple Negative Breast NeoplasmsHumansAnimalsFemaleHafnium

Stichwörter der Autor:innen

In situ biomineralizationextracellular electron transferliving biointerfacetriple-negative breast cancertumor microenvironment remodeling

Substanzen

titanium dioxideTitaniumhafnium oxideOxidesHafnium

Autor:innen und Institutionen

  • Department of Pharmacy, The Second Xiangya Hospital of Central South University, Changsha, Hunan410011, China.
  • Institute of Clinical Pharmacy, Central South University, Changsha, Hunan410011, China.
  • Hunan Provincial Engineering Research Centre of Translational Medicine and Innovative Drug, Changsha, Hunan410011, China.
  • Department of Pharmacy, Hunan Cancer Hospital, The Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University, Changsha, Hunan410011, China.
  • State Key Laboratory of Neurology and Oncology Drug Development, Nanjing, Jiangsu210000, China.

ORCID-Profile: Daxiong Xiang, Junyong Wu

Förderung

  • Central South University
  • Xiangya Hospital, Central South University
  • Science and Technology Program of Hunan Province
  • Natural Science Foundation of?Hunan Province
  • National Natural Science Foundation of China (NSFC)

Zitieren

APA

Guo, M., Sun, P., Xu, W., Hao, X., Tang, T., Liu, X., Liao, D., Zhao, J., Huang, H., Li, M., Xu, L., Lin, J., Peng, Y., Zhang, X., Hu, X., Xiang, D., & Wu, J. (2026). Electrogenic HfO2/TiO2 Living Biointerface Dismantles Metabolic Radioresistance for Amplified Radio-Immunotherapy. ACS Nano. https://doi.org/10.1021/acsnano.6c08241

Vancouver

Guo M, Sun P, Xu W, Hao X, Tang T, Liu X, et al. Electrogenic HfO2/TiO2 Living Biointerface Dismantles Metabolic Radioresistance for Amplified Radio-Immunotherapy. ACS Nano. 2026. doi:10.1021/acsnano.6c08241

BibTeX
@article{Guo2026,
  author = {Guo, Mengen and Sun, Pengcheng and Xu, Wenjie and Hao, Xinyan and Tang, Tiantian and Liu, Xinying and Liao, Dehua and Zhao, Jiangshan and Huang, Hai and Li, Muyan and Xu, Linghao and Lin, Jianing and Peng, Yanjin and Zhang, Xinfeng and Hu, Xiongbin and Xiang, Daxiong and Wu, Junyong},
  title = {Electrogenic HfO2/TiO2 Living Biointerface Dismantles Metabolic Radioresistance for Amplified Radio-Immunotherapy},
  journal = {ACS Nano},
  year = {2026},
  doi = {10.1021/acsnano.6c08241}
}
Kostenlos starten →